Answers are grounded in this paper and cite their sources.
Background Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections, hospitalizations, and deaths, particularly among infants and older adults worldwide. This study aims to summarize cost-effectiveness evidence by pooling incremental net benefit (INB) estimates of marketed RSV vaccines. Methods In this review, PubMed, Embase, Web of Science, and the Cochrane Library were searched through November 20, 2025. Grey literature and reference lists were also searched. Random-effects meta-analyses were conducted separately for older adults and infants. Potential sources of heterogeneity were explored using population-specific subgroup analyses and univariable meta-regressions. Results Of the 17 studies included in the systematic review, 11 contributed to the primary meta-analysis and one additional study to sensitivity analysis only. Among older adults, the pooled INB was USD 105.05 [95% confidence interval ( CI ): USD 41.89–168.21; I 2 = 93.2%]. For infants, the pooled INB was USD 5.81 (95% CI: USD − 35.44–47.07; I 2 = 89.4%). In the European subgroup, the pooled INB among older adults was USD 123.63 (95% CI: USD 41.23–206.02; I 2 = 89.4%), while that for infants was USD 15.00 (95% CI: USD − 4.33–34.34; I 2 = 43.4%). Leave-one-out sensitivity analyses showed robust pooled INBs among older adults, whereas infant estimates were sensitive to study exclusion. Conclusions At the thresholds used in the included studies, RSV vaccination might be cost-effective for older adults in post-marketing settings, while the evidence for maternal vaccination remained inconclusive. Descriptive findings suggested that age- and risk-based targeting in older adults and seasonal maternal vaccination may yield higher INB estimates. Substantial between-study heterogeneity warrants cautious interpretation of the pooled estimates and highlights the need to consider local epidemiology and implementation conditions when developing RSV vaccination policies.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: